Julian Goggi
0000-0002-3021-3184
Publication & Citation Trends
Publications
0 total
Abstract C091: Validation of the U87MG human glioblastoma cell line xenograft model as a platform for the development of radioligand therapy and other targeted therapeutics
Cited by 0
Semantic Scholar
Facile Automated Radiosynthesis of an Arginine Selective Bioconjugation Reagent 4‑[18F]Fluorophenylglyoxal for Developing Protein-Based PET Molecular Probes
Cited by 0
Semantic Scholar
Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya OA
Cited by 12
Semantic Scholar
Novel [18F]FPG-interleukin-2 conjugate for monitoring immune checkpoint therapy with positron emission tomography. OA
Cited by 2
Semantic Scholar
Arginine-Selective Bioconjugation Reagent for Effective 18F-labeling of Native Proteins OA
Cited by 5
Semantic Scholar
Mitochondrial complex I as a diagnostic and therapeutic target in a mouse model of tauopathy OA
Cited by 1
Semantic Scholar
A Novel Prosthetic group, 4-[18F]Fluorophenylglyoxal for Protein Conjugation
Cited by 0
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(10)
Radiopharmaceutical Chemistry and Applications
(8)
Neuroscience and Neuropharmacology Research
(6)
Nerve injury and regeneration
(6)
Immune Cell Function and Interaction
(6)
Affiliations
Agency for Science, Technology and Research
National University of Singapore
General Electric (Spain)
Hammersmith Hospital
Duke-NUS Medical School